Judy Yu Ying Nie, Music Therapist-Board Certified: No financial or non-financial relationships to disclose
Abstract: Language, speech, and music share structural characteristics and neural processing areas that represent our abilities to process complex sound and structure. Studying their similarities and differences in a therapeutic context informs how speech-language pathologists (SLPs) and music therapists (MTs) can collaborate to maximize the efficacy of treating individuals with acquired neurogenic disorders. SLPs possess the important knowledge of speech and language, and clinical skills to treat acquired neurogenic disorders. MTs use music clinically to increase the motivation of clients by targeting speech/language areas and ensuring their social and emotional well-being. This presentation aims to provide a review of literature that explores the collaboration of speech therapists and music therapists in the treatment of acquired neurogenic disorders.
Summary of Presentation : This presentation explores the collaboration of speech-language pathologists (SLPs) and music therapists (MTs) in the treatment of acquired neurogenic disorders. The theoretical underpinnings of using speech and music interventions to treat acquired neurogenic disorders will be discussed. In addition, the presenter will discuss clinical and evidence-based methods of implementing music therapy techniques into speech-language therapy goals to treat acquired neurogenic disorders.
Learning Objectives:
At the completion of this activity, participants should be able to:
Upon completion, participant will be able to describe the similarities and differences of structural characteristics and neural processing areas of language, speech, and music.
Upon completion, participant will be able to explain therapeutic applications of combining speech and music interventions to treat acquired neurogenic disorders.
Upon completion, participant will be able to describe evidence-based clinical interventions that combine speech and music therapy in treating acquired neurogenic disorders.